Strategic Fund Moves Gilde Healthcare actively expands its portfolio through new funds and strategic acquisitions, including the Climate Solutions fund and recent investments in vascular and neuroimaging technologies. This signals opportunity for partnerships with portfolio companies seeking scale, mergers, or co‑investments in medtech, digital health, and therapeutics.

Regional Focus The firm emphasizes Europe with a Netherlands/Belgium/Germany tilt in lower mid-market healthcare services, alongside North American investments in medtech and digital health. This suggests strong potential for cross-border collaborations, licensing deals, and exit opportunities within these geographies.

Recent Wins Recent investments and acquisitions include Endovascular Engineering Series C funding, NIRx Medical Technologies acquisition, and Artinis pairing, indicating a preference for vascular, neuroimaging, and diagnostic tech. Sales conversations could target providers and vendors in these segments for partnerships, distribution, or technology integrations.

Technology Stack Gilde relies on modern platforms (Salesforce, WordPress, Azure, DigitalOcean, Docusign) to manage investments and portfolio operations, implying ease of engagement, data sharing, and streamlined onboarding for potential co‑investors and portfolio companies.

Financial Signals With a revenue band of several tens of millions and a history of raising large specialized funds (€2.5B raised since 2001), Gilde is financially robust and actively deploying capital. This positions them as a credible partner for large ticket opportunities, co‑investments, and structured exits with potential for favorable deal terms.